Cargando…
Targeted Next Generation Sequencing for Human Papillomavirus Genotyping in Cervical Liquid-Based Cytology Samples
SIMPLE SUMMARY: Testing for Human Papillomavirus (HPV) is currently being implemented as part of cervical cancer (CC) screening in several countries. However, infections with all but one of the HPV types classified as possibly carcinogenic cannot be detected by the assays used for CC screening today...
Autores principales: | Andersen, Karoline, Holm, Kasper, Tranberg, Mette, Pedersen, Cecilie Lebech, Bønløkke, Sara, Steiniche, Torben, Andersen, Berit, Stougaard, Magnus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833452/ https://www.ncbi.nlm.nih.gov/pubmed/35158920 http://dx.doi.org/10.3390/cancers14030652 |
Ejemplares similares
-
Implementation of p16/Ki67 dual stain cytology in a Danish routine screening laboratory: Importance of adequate training and experience
por: Hammer, Anne, et al.
Publicado: (2020) -
Evidence of No Association Between Human Papillomavirus and Breast Cancer
por: Bønløkke, Sara, et al.
Publicado: (2018) -
The Diagnostic Value of Circulating Cell-Free HPV DNA in Plasma from Cervical Cancer Patients
por: Bønløkke, Sara, et al.
Publicado: (2022) -
Urine collection in cervical cancer screening – analytical comparison of two HPV DNA assays
por: Tranberg, Mette, et al.
Publicado: (2020) -
Impact of opportunistic testing in a systematic cervical cancer screening program: a nationwide registry study
por: Tranberg, Mette, et al.
Publicado: (2015)